ValiRx Share Price | |
---|---|
Price | 3.55 |
Bid | 3.50 |
Ask | 3.60 |
Change | -0.30 (-7.79%) |
Volume | 888,756 |
Open | 3.85 |
High | 3.85 |
Low | 3.55 |
Prev. Close | 3.85 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 132.35m |
Market Capitalisation | £4.70m |
Market Size | 15,000 |
52 Week High | 14.75 |
52 Week High Date | 03-Nov-2023 |
52 Week Low | 3.55 |
52 Week Low Date | 14-Mar-2024 |
# Trades | 19 |
---|---|
Vol. Sold | 562,832 |
Sold Value | £20.20k |
Vol. Bought | 276,544 |
Bought Value | £9.93k |
PE Ratio | -1.160131 |
Earnings | -3.06 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-Mar-24 | 16:19:20 | 3.585 | 20,000 | Buy* | 3.50 | 3.60 | 717.00 | O Ordinary |
28-Mar-24 | 16:15:52 | 3.55 | 13,380 | Unknown* | 3.50 | 3.60 | 474.99 | O Ordinary |
28-Mar-24 | 16:05:13 | 3.55 | 36,000 | Unknown* | 3.50 | 3.60 | 1,278 | O Ordinary |
28-Mar-24 | 16:02:18 | 3.505 | 60,340 | Sell* | 3.50 | 3.60 | 2,115 | O Ordinary |
28-Mar-24 | 16:01:50 | 3.59 | 250,000 | Buy* | 3.50 | 3.60 | 8,975 | O Ordinary |
28-Mar-24 | 14:47:33 | 3.5038 | 7,704 | Sell* | 3.50 | 3.70 | 269.93 | O Ordinary |
28-Mar-24 | 14:41:42 | 3.6375 | 6,544 | Buy* | 3.50 | 3.70 | 238.04 | O Ordinary |
28-Mar-24 | 12:56:15 | 3.51 | 4,775 | Sell* | 3.50 | 3.70 | 167.60 | O Ordinary |
28-Mar-24 | 12:15:28 | 3.50 | 75,419 | Sell* | 3.50 | 3.70 | 2,640 | O Ordinary |
28-Mar-24 | 10:50:53 | 3.52 | 57,088 | Sell* | 3.50 | 3.70 | 2,009 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Jul-22 | 07-Jul-22 | Placing | Gerald Desler held the position of CFO at the time of this trade.Gerald Desler | 10.00 | GBX | 25,000 | 128,668 |
07-Jul-22 | 07-Jul-22 | Placing | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 10.00 | GBX | 100,000 | 372,333 |
07-Jul-22 | 07-Jul-22 | Placing | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 10.00 | GBX | 100,000 | 144,000 |
07-Jul-22 | 07-Jul-22 | Placing | Suzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly | 10.00 | GBX | 100,000 | 416,668 |
18-Feb-21 | 17-Feb-21 | Buy | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 22.25 | GBX | 22,000 | 272,333 |
Click here to read more about our shareholder information - providing intellectual, corporate and financial support in the early stages of drug development.